Since the synthesis of DSG2 needs several posttranslational modifications such as glycosylation and vesicular trafficking (from the ER to the Golgi apparatus, and finally to the plasma membrane), ARVC-related variants might affect transport or modification of the molecule. This evidence concerns the gene DSG2 and arrhythmogenic right ventricular cardiomyopathy.